EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS060-03967 
Organism
Homo sapiens 
Tissue/cell
GM12891 
Coordinate
chr10:64374060-64375000 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ELF5MA0136.2chr10:64374611-64374622ACCCGGAAGTT+6.14
JUN(var.2)MA0489.1chr10:64374249-64374263GGAGGATGAGTCAT+6.06
JUN(var.2)MA0489.1chr10:64374254-64374268ATGAGTCATTCCCC-6.59
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_09310chr10:64374261-64375476CD14
SE_56132chr10:64372344-64376327u87
SE_62027chr10:64370035-64415724Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr106437417964374536
Number: 1             
IDChromosomeStartEnd
GH10I062613chr106437302064375300
Enhancer Sequence
AACACAATCC TAACTGCCAC TTGACTACCC ATGGCCTAGG GGAGTAAACA GATTTCTAAG 60
ATATGATGCC TTCCAGGTTG ATAAGCAGTT ATGTGAACAG AGCACAGAAT GGATAGATCT 120
GCTTTGATGG AGGAGAAACA ACTGGTCAAA AAGGGTTTCG GAAAGGAAGA GATGCTTGAG 180
TTGGGTCTTG GAGGATGAGT CATTCCCCAG CCACGAAGGA GTAGAAATGG CATCCAGGTT 240
GACAGGACAT ACACGCAAAG ACAAGAGAAG TGAAATAACG TGGCACACTC AATAATGTCG 300
CTGAAATGAC TTCATCTGAC TGGGAAGAGG ATGCTTGTGG GATGAGGTGG GGGATGACAT 360
CGAAGAGGGT AGAAGCCAGG TCATAAAAAG ACTTGTGGGA TCTTGGACAA GTCACAAAGC 420
CAGTTCACCT CCAGTTTCCT CAGCTATAAA GAGAGGGGGT TCACTGAGAG GAGGGGGTAG 480
CTCTGACCAG GGGGCTGCTC TGCAACCATC CCTTGCGGAA CACTGGTTGG AGGCTCTGGC 540
TCCTTTGCAA GACCCGGAAG TTTCCACAGG AAGTGCTGTC CTGCCTGGCC CGCCTCCCTT 600
GGTTTCACAC TGCATGGTGT AGTCCAAGGA CTGCACTGGC ATTTCAGTTT GAACACTAAG 660
CGGTGACTCA GAACCAACAG AAGTGTGGAC AACTGTTTAC TAAGAAGGCA GCCTTTGGTG 720
TGACAAATTA GAGTGGGCTG CTGGATTGTG CAGCACTCAT GAGCTAGGCA GCTTGGAAAT 780
AGCACATACC ATCGCATTGG GCAGTTGATT CATTTCTTGT CCTGTCTTGC CAGGCAGGGC 840
ATCACATGCC AACCCAGTCA GACCCACCAT CTATATCCAG GCCAGGGGAA GTGTTCTTTT 900
TTTCTTTTTC TTTTTCTGGA TGATGCCTTA AGTACTCTGA 940